πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,641 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6921634

Replication competent hepatitus C virus and methods of use

The Board of Regents of the University of Texas System Β· Granted Tue Jul 26 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6913757

Live, avirulent strain of V. anguillarum that protects fish against infection by virulent

Board of Governors for Higher Education, State of Rhode Island and Providence Plantations Β· Granted Tue Jul 05 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6905873

Recombinant p53 adenovirus methods and compositions

The Board of Regents of the University of Texas System Β· Granted Tue Jun 14 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6906169

Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MU

United Biomedical, Inc. Β· Granted Tue Jun 14 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6893643

Recombinant yellow fever virus and methods of use thereof

The Regents of the University of California Β· Granted Tue May 17 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6893869

Enhanced immune response to an antigen by a composition of a recombinant virus expressing

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue May 17 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6884414

Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents

The United State of America as represented by the Department of Health and Human Services Β· Granted Tue Apr 26 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6869925

Inhibition of retrovirus infection

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 22 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6867353

Production method of recombinant rotavirus structural proteins and vaccine composition

Exploregen Inc. Β· Granted Tue Mar 15 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6867022

Replication deficient adenovirus vectors and methods of making and using them

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Mar 15 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6855315

Kits for detecting swine infertility and respiratory syndrome (SIRS) virus

Regents of the University of Minnesota Β· Granted Tue Feb 15 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6852324

Immunization for ebola virus infection

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 08 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6849736

Crystalline forms of valacyclovir hydrochloride

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Feb 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6849429

Viral pseudo-capsids including assembly agonists and antagonists

The Board of Regents of the University of Texas System Β· Granted Tue Feb 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6849737

Synthesis and purification of valacyclovir

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Feb 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6849605

Inhibitors of serine protease activity, methods and compositions for treatment of viral in

The Regents of the University of Technology Office of Technology Transfer Β· Granted Tue Feb 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6849610

Polynucleotide ligands as anti-viral agents

The Regents of the University of California Β· Granted Tue Feb 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6846652

Viral vectors having enhanced effectiveness with reduced virulence

THE ARIZONA BOARD OF REGENTS Β· Granted Tue Jan 25 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6838237

Antigenically reactive regions of the hepatitis a virus polyprotein

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 04 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6830749

Recombinant P53 adenovirus methods and compositions

The Board of Regents of the University of Texas System Β· Granted Tue Dec 14 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6824976

Method for selective inactivation of viral replication

Rigel Pharmaceuticals, Inc. Β· Granted Tue Nov 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6821511

Methods of using adeno-associated virus rep protein

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 23 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6811775

Reovirus for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. Β· Granted Tue Nov 02 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6808916

Method of extracting virus from cell culture

ONCOLYTICS BIOTECH INC. Β· Granted Tue Oct 26 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired